Ripstein David 4

What Happened David Ripstein, a director of Ceragon Networks Ltd. (CRNT), was granted equity compensation in late May 2026. On 05/22/2026 and 05/23/2026 he received a total of 21,270 ordinary shares via fully vested RSUs (6,520 on 05/22 and 14,750 on 05/23) and was granted stock options covering 42,530 shares (13,030 on 05/22 and 29,500 on 05/23). All grants show a $0 acquisition price (these were awards/grants, not open-market purchases). The RSUs were fully vested and automatically settled into ordinary shares on their grant dates; the options were fully vested and immediately exercisable upon grant.

Key Details

• Transaction dates: RSUs and option grants dated 05/22/2026 and 05/23/2026; Form 4 filed 05/26/2026 (Accession 0001976408-26-000482).
• Price: $0.00 reported for all line items (standard for awards/grants).
• Shares acquired (issued): 21,270 ordinary shares via RSU settlement (6,520 + 14,750).
• Derivative securities granted: Options covering 42,530 shares (13,030 + 29,500); options were fully vested and immediately exercisable.
• Shares owned after transaction: Not specified in the details provided.
• Footnotes: F1–F2 confirm RSUs each convert to one share and were fully vested and auto-settled on their grant dates. F3–F4 confirm option grants were fully vested and immediately exercisable on grant dates.
• Filing timeliness: Form filed 05/26/2026 for transactions on 05/22–05/23/2026; this appears to fall within the typical SEC Form 4 reporting window.

Context

• RSUs settled into ordinary shares are compensation awards and do not reflect an open-market purchase; they typically result from company compensation plans.
• The option grants are vested and exercisable, but the filing does not show any exercise or sale of the optioned shares—no cashless exercises or market sales were reported.
• These transactions are disclosure of insider grants, not sales, and should be viewed as company compensation activity rather than an insider purchase/sell signal.